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ing by ElsAbstract Purpose: To assess the feasibility of apparent diffusion coefﬁcient (ADC) generated
from diffusion weighted magnetic resonance imaging as a non invasive technique to differentiate
tumor recurrence from radionecrosis in patients with laryngeal carcinoma.
Materials and methods: Twenty one patients suspected of tumor recurrence underwent MRI includ-
ing diffusion weighted imaging (DWI) (b 0 and 1000). ADC maps were generated and ADC values
were measured at the lesion sites and the normal laryngeal tissues, and were compared with the his-
topathological results.
Results: The mean ADC of tumor recurrence {1.04 ± 0.34 · 103 mm2/s (SD)} was signiﬁcantly
lower (p< 0.0001) than the mean ADC of the normal laryngeal tissues in the same patient
(1.48 ± 0.099 · 103 mm2/s) while the mean ADC of radionecrosis (1.79 ± 0.41 · 103 mm2/s)
was signiﬁcantly higher (p< 0.04) than the mean ADC of the normal laryngeal tissues
(1.49 ± 0.095 · 103 mm2). The mean ADC of tumor recurrence is signiﬁcantly lower (p< 0.0001)4038955.
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170 G.K. Gouhar, M.A. El-Haririthan the mean ADC of radionecrosis with 1.16 · 103 mm2/s is the best cut value for differentiating
tumor recurrence from radionecrosis.
Conclusion: ADC can differentiate tumor recurrence from radionecrosis in laryngeal carcinoma.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.Figure 1 ROC curve for use of ADC values in differentiating
tumor recurrence from radionecrosis. The area under the curve is
0.962.1. Introduction
Conventional imaging techniques can detect tumors by identi-
ﬁcation of anatomic distortion or change in tissue appear-
ances. However, the effects of therapy may obscure or mimic
recurrent disease (1).
DWI technique gives information about water molecule dif-
fusion motions of tissues (2). In biologic tissues, totally free
diffusion of molecules does not exist due to restriction, such
as that owing to cell membranes or molecular boundaries
(3). The extent of translational diffusion of molecules mea-
sured in the human body is referred to as the apparent diffu-
sion coefﬁcient (ADC). ADCs are expected to vary
according to the microstructures and pathophysiologic states
of tissues (4).
DWI was used successfully in the evaluation of brain le-
sions but its application in the head and neck region has been
limited because the images in this area are likely to have mo-
tion related artifacts from respiratory and swallowing move-
ments, and susceptibility artifacts due to the anatomic
heterogeneity of the area or the presence of dental work, as
well as adjacent air and bone (5). However the development
of new applications allows the use of DWI in the head and
neck region for the differential diagnosis, recurrence diagnosis
and assessment of response to therapy (2,6–13).
Hypercellular tissue, such as occurring within malignant tu-
mors, will show low ADC values. Non-tumoral tissue changes
such as edema, inﬂammation, ﬁbrosis, and necrosis are ex-
pected to show low cellularity, in strong contrast with viable
tumor. This results in high ADC (14). So DWI can be used
to evaluate the larynx for tumor recurrence after prior radio-
therapy (1,15–17).
The aim of this study is to assess the feasibility of ADC gen-
erated from DWI as an alternative non invasive technique to
differentiate tumor recurrence from radionecrosis in patients
with suspected tumor recurrence after radiotherapy from lar-
yngeal carcinoma.
2. Materials and methods
2.1. Patients
Our prospective study included 21 patients (16 male and 5
female patients with mean age, 59 years; age range, 47–
66 years). Inclusion criteria in this study were patients sus-
pected of tumor recurrence 2–6 months after completion of
radiotherapy for laryngeal carcinoma. Exclusion criteria were
contraindication to MR imaging (e.g., pacemaker, metallic im-
plant, or claustrophobia). All patients underwent MR imaging
including conventional and diffusion weighted imaging then
biopsies were taken from the lesions for histopathological
examination within 2–5 days of MRI examination. The study
followed the principles of the Declaration of Helsinki and In-
formed consent was taken from all the patients.2.2. MR imaging protocol
Each patient included in the study underwentMR imaging on a
1.5-T MR (Achieva, Philips Medical Systems, The Netherlands
B.V.). After localizer images, conventional images were ob-
tained including transverse T1-weighted images ((500–600/8–
9) repetition time ms/echo time ms) and T2-weighted fast spin
echo images (3000/100) were obtained in the transverse plane,
with a section thickness of 4 mm, an intersection gap of 0.4
or 0.5 mm, a ﬁeld of view (FOV) of 170–250 mm and a ﬂip an-
gle of 90. A total of 20 transverse images cover the lesions.
When necessary, one or more pulses of T1- or T2-weighted se-
quences were added in the coronal and sagittal plane, with the
same pulse sequence parameters. T1-weighted images were
performed before and after administration of 15 ml of gado-
pentetate dimeglumine. Additional coronal and sagittal T1 se-
quences after contrast administration were done depending on
tumor localization.
DWI were acquired with 20 slices in the transverse plane, 3–
4 mm slice thickness, 1 mm intersection gap, FOV 20 cm, TR/
TE2000-2600 ms/64-70 ms. The images were acquired using b-
values (b 0 and 1000). Apparent diffusion coefﬁcient (ADC)
maps were automatically calculated by MRI machine software
and included in the sequence. On ADC map multiple regions
of interest (ROIs) were placed over the normal areas of the lar-
ynx at the supraglottic, glottic and infraglottic levels and aver-
aged, excluding the site of any suspect lesions, then, the (ROIs)
were placed over the lesion and ADC were measured. MR
Figure 2 Axial contrast enhanced T1 weighted MR image shows heterogeneously enhanced lesion at the left hemi-larynx causing
encroachment upon the lumen (a). The lesion shows high signal intensity at DWI b 1000 (b) and low signal intensity (\) at ADC map (c).
Pathologically the lesion was proved to be recurrence.
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two radiologists sharing the study.
2.3. Statistical analysis
Statistical analysis was done using SPSS version 10. The mean
and standard deviation were calculated for the ADC values of
recurrent tumors and radionecrosis at the sites of the lesions
and the other normal laryngeal sites in the same patients.Using paired t-test to evaluate the mean ADC at tumor recur-
rence, radionecrosis and normal laryngeal tissues in the same
patients, and independent t-test to evaluate the mean ADC
at tumor recurrence and radionecrosis. The probability (p va-
lue) was considered signiﬁcant when (p< 0.5).
We used the receiver operating characteristic (ROC) curve
to evaluate the diagnostic capability of the ADC value for
use in the differentiation between tumor recurrence and radio-
necrosis, and then we used multiple thresholds of ADC values
Figure 3 Axial contrast enhanced T1 weighted MR image shows heterogeneously enhanced lesion involving the glottis region more on
the left side of the larynx (a). At DWI b 1000 (b) the lesion displays high signal intensity however it shows low signal intensity (\) at ADC
map (c). This lesion was proved pathologically to be recurrence.
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ferentiating tumor recurrence from radionecrosis.
3. Results
A total of 21 patients with suspected tumor recurrence after
radiotherapy from laryngeal carcinoma underwent MRI
including conventional and diffusion weighted images fol-lowed by histopathological examination of the taken biopsies
from the lesions within 2–5 days of MRI examination.
According to the histopathological examination the pa-
tients were divided into 13 patients with tumor recurrence
and eight patients with radionecrosis. In DWI the images were
acquired using b values (b 0 and 1000).
In tumor recurrence (Figs. 2 and 3) the lesions were hyperin-
tense or asymmetric hyperintensity (due to focal lesion of abnor-
Figure 4 Axial contrast enhanced T1 weighted MR image (a) shows heterogenously enhancement lesion at the infraglottic laryngeal
region. No signiﬁcant asymmetrical hyperintensity can be detected by DWI b 1000 (b). ADC map (c) shows hyperintensity (\) at the same
site of the lesion. The lesion was pathologically proved to be inﬂammatory changes with no tumor recurrence.
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sue) on DWI (b 1000) and hypointense on ADCmap. The mean
ADC for tumor recurrence was 1.04 ± 0.34 · 103 mm2/s and
was signiﬁcantly lower (p< 0.0001) than the mean ADC of
the normal laryngeal tissues within the same patients which
was 1.48 ± 0.099 · 103 mm2/s.
In radionecrosis (Fig. 4) the lesions were hypointense or of
slight symmetric hyperintesity (no clear focal lesion of abnor-
mal high signal intensity) on DWI (b 1000) and hyperintensityon the ADC map. The mean ADC for radionecrosis was
1.79 ± 0.41 · 103 mm2/s and was signiﬁcantly higher (p<
0.04) than the ADC of the normal laryngeal tissues within
the same patients which was 1.49 ± 0.095 · 103 mm2/s.The
mean ADC of the tumor recurrence was signiﬁcantly lower
(p< 0.0001) than the mean ADC of radionecrosis (Table 1).
The ROC curve for use of ADC values in differentiating tu-
mor recurrence from radionecrosis is shown in Fig. 1. The area
under the ROC curve 0.962, 95% CI: 0.888–1.035.
Table 2 Validity of ADC in prediction of recurrence at different ADC values.
ADC value Sensitivity % Speciﬁcity % PPV % NPV % Kappa test p Value
0.85 23 100 100 44 0.18 0.14
1.01 69 100 100 67 0.63 0.002
1.16* 85 88 92 78 0.7 0.001
1.49 85 75 85 75 0.59 0.006
2.22 100 13 65 100 0.15 0.19
* Best cut off value for differentiating recurrence from radionecrosis.
Table 1 Mean ADC values in recurrent, radionecrosis lesions, and normal tissue.
Lesion ADC (mean ± SD)* Normal ADC (mean ± SD) Paired t-test p Value
Recurrence (13) 1.04 ± 0.34 1.48 ± 0.099 5.34 <0.0001
Necrosis (8) 1.79 ± 0.41 1.49 ± 0.095 2.39 <0.04
* Independent t-test of ADC of tumor recurrence to ADC of radionecrosis = 4.55, p value < 0.0001.
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entiate tumor recurrence from radionecrosis after radiotherapy
from laryngeal carcinoma it showed, sensitivity of 85%, spec-
iﬁcity 88%, positive predictive value 92%, negative predictive
value 78%, accuracy using kappa test 0.7 and p value of 0.001
(Table 2).
4. Discussion
A new emerging functional technique that has now a role in
cancer imaging is the DWI which gives information about tis-
sue cellularity and integrity of cell membranes (1). DWI was
reported to discriminate treatment induced tissue changes
from tumor recurrence after chemo(radiotherapy) as hypercel-
lular tissue such as occurring within malignant tumors will
show low ADC values. Non tumoral tissue changes such as
edema, inﬂammation, ﬁbrosis and necrosis are expected to
show low cellularity in strong contrast with viable tumors
and leads to higher ADC values (13). DWI also appears to of-
fer a better discrimination between neoplastic disease and
inﬂammatory changes than PET. DWI is a method that can
be performed at a lower cost than PET, without the need for
an external tracer, and without exposure of the patient to ion-
izing radiation (14).
Our study included 13 patients with tumor recurrence. The
lesions were hyperintense on DWI (b 1000) and hypointense
on the ADC map. The mean ADC of these lesions was signif-
icantly lower than the mean ADC of the normal laryngeal tis-
sues in the same patients. These ﬁndings are in agreement with
the previous four cases study (18) that had two cases with tu-
mor recurrence which were hyperintense on b 1000 and
hypointense on the ADC map, the ADC of the ﬁrst case
was 0.83 · 103 mm2 s1 at the lesion site and 1.43 · 103
mm2 s1 at the normal sites while the ADC in the second case
was 0.96 · 103 mm2 s1 at the lesion site and 1.41 · 103
mm2 s1 at the normal sites. We also had eight patients with
radionecrosis; the lesions show no asymmetric or slight sym-
metric hyperintesity on DWI (b 1000) and were hyperintense
on the ADC map. The mean ADC was signiﬁcantly higher
than the ADC of the normal laryngeal tissues in the same pa-
tients. This is inconsistent with the previous study (18) that
had two cases with radionecrosis; in the ﬁrst patient the b1000 images showed no asymmetric hyperintense signal and
the ADC map showed diffuse hyperintensity with an ADC va-
lue of 1.84 · 103 mm2 s1 while in the second patient the
DWI showed only slight symmetric hyperintensity on the b
1000 images in the laryngeal soft tissues and appeared hyper-
intense on the ADC map, with ADC value of 1.87 · 10
3 mm2 s1. Previous studies (19,20) compared the ADC
changes with the treatment response in patients with squa-
mous cell carcinoma of the head and neck. These studies
(19,20) showed that there is a signiﬁcant increase in ADC in
complete treatment responders than partial responders in the
ﬁrst week after chemotherapy.
The mean ADC of the tumor recurrence was signiﬁcantly
lower than the mean ADC of radionecrosis. This is consistent
with the other previous studies (18,3) that studied the charac-
terization of head and neck lesions with DWI and found that
the mean ADC of malignant lesions such as lymphoma and car-
cinoma is signiﬁcantly lower than the benign solid and benign
cystic masses. Our study is also consistent with the previous
study (21) where the mean ADC value of residual or recurrent
head and neck tumors (1.17 ± 0.33 · 103 mm2/s) was less
than that of post therapeutic changes (2.07 ± 0.25 ·
10_3 mm2/s). Other studies (2,9) compared the DWI in both
well and poorly differentiated carcinoma and reported that
the ADC values of well differentiated carcinoma are higher
than those of poorly differentiated carcinoma as the increases
in the cellularity and cellular turnover which are frequently ob-
served in malignant tumors, reduce the extracellular matrix and
the diffusion space of water protons in the extracellular and
intracellular dimensions, with a resultant decrease in ADC
values.
The ADC value of 1.16 · 103 mm2/s was the best cut off
value for differentiating tumor recurrence from radionecrosis.
The previous study (3) found that the ADC value of 1.22 · 103
mm2/s or less was the best cut off value for predicting malig-
nancy, with highest accuracy of 86%, with 84% sensitivity,
91% speciﬁcity, 93% positive predictive value and 78% nega-
tive predictive value. Previous study (21) used an ADC value
of 1.30 · 103 mm2/s as the threshold value for differentiating
residual or recurrent head and neck lesions from post
therapeutic changes, the best results were obtained with
an accuracy of 87%, sensitivity of 84%, speciﬁcity of 90%,
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of 76%.
One of the limitations of this study is the small number of
the studied population, second is a technical limitation as we
used only two b values (b= 0 and 1000) which may affect
the accuracy of the measured ADC, third is the susceptibility
artifacts from air inside the larynx which make it difﬁcult to
measure ADC values in small lesions.
In conclusion, DWI is a non invasive alternative technique
that can be used in patients with suspected tumor recurrence
after radiotherapy from laryngeal carcinoma to discriminate
tumor recurrence from radiation induced changes. Being a
short time examination sequence DWI can be safely added
to the standard MRI protocol in order to achieve better diag-
nostic criteria with minimum patient discomfort.
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